- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04478578
Incidenser, orsaker och resultat av febersjukdom på landsbygden i Syd- och Sydostasien (SEACTN-WP-A)
Fastställande av förekomst, orsaker och resultat av landsbygdens febersjukdom (RFI) i Syd- och Sydostasien, som en del av South and Southeast Asian Community-based Trials Network (SEACTN). Arbetspaket A (WP-A).
The study will collect information to understand the causes and outcomes of febrile illness in rural areas in countries across South and Southeast Asia (including Cambodia, Laos, Myanmar and Bangladesh). The findings will be used to identify new tests and treatments that can improve the management of febrile patients in the future.
This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
This study aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people living in rural areas in South and Southeast Asia, all on a scale which has not been attempted before. The SEACTN RFI project will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. Determining the incidence, causes and outcomes of febrile illness in these settings will be done through two work packages. The first of these, Work Package A (WP-A), the subject of this study, will be carried out at the community level, primarily by engaging village health worker (VHWs) and low-level Health Centres (HCs) which serve the communities to recruit patients presenting with a febrile illness. These patients will be assessed for presenting symptoms and followed up for clinical outcomes. Collection of specimen for diagnostic investigations in these settings is challenging. Currently, mRDTs are conducted by VHWs and HCs in these networks, therefore by using the same process, but also applying blood to filter paper and allowing it to dry (DBS), investigators will test for certain other pathogens, which will increase the aetiological yield.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Dhaka, Bangladesh, 1212
- Building Resources Across Communities (BRAC)
-
-
-
-
-
Yangon, Burma, 11201
- Medical Action Myanmar (MAM)
-
-
-
-
-
Battambang, Kambodja
- Action for Health Development (AHEAD)
-
-
-
-
Vientiane Prefecture
-
Vientiane, Vientiane Prefecture, Laos, 01000
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)
-
-
-
-
-
Chiang Rai, Thailand, 57000
- Chiangrai Clinical Research Unit (CCRU)
-
-
Bangkok
-
Ratchathewi, Bangkok, Thailand, 10400
- Mahidol VivaResearch Unit, Faculty of Tropical Medicine, Mahidol University (MVRU)
-
-
Changwat Tak
-
Mae Sot, Changwat Tak, Thailand, 63110
- Shoklo Malaria Research Unit (SMRU)
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Patients with an acute febrile illness of all ages presenting to village health workers (VHWs) or peripheral health facilities.
Beskrivning
Inclusion Criteria:
- Documented fever (≥ 37.5°C axillary), hypothermia (< 35.5°C) and/or history of fever in the last 24 hours.
- Willingness and ability to comply with study protocol for the study duration.
- Written informed consent given to participate in the trial.
Exclusion Criteria:
- Currently enrolled in the study
- Accident or trauma is the cause for presentation
- Presentation ≤ 3 days after routine immunisations
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: CASE_ONLY
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Patients with febrile illness
Participants from approximately 650 villages, with a target number of 100,000 episodes of febrile illness, will be enrolled into this study. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Local incidence of febrile illness
Tidsram: From Months 0 to 24
|
The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the village level. |
From Months 0 to 24
|
|
Overall incidence of febrile illness
Tidsram: From Months 0 to 24
|
The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the regional level. These estimates will later be triangulated with and extrapolated from using health seeking behavior surveys for an estimate of the total incidence of febrile illness. |
From Months 0 to 24
|
|
Mortality
Tidsram: Within approximately 1 month of first presentation to the village health worker or health facility
|
Case fatality rates in febrile illness |
Within approximately 1 month of first presentation to the village health worker or health facility
|
|
Morbidity
Tidsram: Over 1 month after first presentation
|
Duration of illness in patients presenting with a fever to the village health worker or health facility. |
Over 1 month after first presentation
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Prevalence of pathogens in febrile patients
Tidsram: Samples collected over approximately 24 months
|
Pathogens will be detected in patients presenting over a 24 month period using point of care tests and diagnostic assays on acute and convalescent dried blood spots. |
Samples collected over approximately 24 months
|
|
The correlation between host biomarker concentrations, aetiological diagnoses and clinical outcomes.
Tidsram: Samples collected over approximately 24 months
|
The area under the curve, sensitivity and specificity of host biomarkers to identify bacterial infections and to predict severe outcomes. |
Samples collected over approximately 24 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Yoel Lubell, Prof, Mahidol Oxford Tropical Medicine Research Unit
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- BAC20001
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.
Tidsram för IPD-delning
After completion of trial activities and reporting
Kriterier för IPD Sharing Access
MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .